Platelet-inhibitor drugs' role in coronary artery disease
Authors:
- Valentin FusterVFValentin Fuster
- Philip C. AdamsPAPhilip C. Adams
- Juan J. BadimonJBJuan J. Badimon
- James H. ChesebroJCJames H. Chesebro
- 1 March 1987
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 29 (5) , 325-346
Abstract
No abstract availableThis publication has 120 references indexed in Scilit:
- Coronary Angioscopy in Patients with Unstable Angina PectorisNew England Journal of Medicine, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1985
- WarfarinNew England Journal of Medicine, 1984
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979